Developer docs
API playgroundTry for free, no card

Search company profiles

FeetMe

Full company profile

uuid0004xgj

Namestring
FeetMe
Legal namestring
FeetMe
Websiteurl
feetme.fr
Company typeenum
Private
Founded yearint
2013
Descriptiontext

FeetMe is a Paris-based digital health company founded in 2013 that develops connected smart insoles and companion software for clinical and athletic gait and plantar pressure assessment. Its hardware platform comprises flexible insoles embedded with eighty pressure sensors sampling at 100Hz, communicating via Bluetooth to a smartphone app (FeetMe Holter) and to a clinical desktop application (FeetMe Podiatrist) that computes dynamic and static gait metrics including peak pressure maps, center of pressure movement, walking symmetry, Romberg Ratio, and Fourier analysis. FeetMe One is CE-marked as a medical device and ISO 13485 / ISO 9001 certifications underpin the company's regulatory positioning for diabetic foot monitoring, while FeetMe Diagnosis targets clinical use cases such as post-surgery assessment and orthotic design, and FeetMe Sport and FeetMe Mysoles extend the platform into athletic performance and custom orthotic fabrication respectively.

The company operates a B2B sales-led and enterprise-field-sales go-to-market, selling exclusively to healthcare professionals (podiatrists, sports medicine specialists, hospitals) via direct contact and quote-based pricing with multi-year contracts; it does not sell direct to consumers and instead connects end users to equipped clinicians through a "Find a Specialist" program on its website. Revenue is generated through hardware sales of the smart insole product lines and licensing of the FeetMe Podiatrist analysis software, with FeetMe Mysoles adding an orthotic manufacturing productized workflow supported by a co-development partnership with Thuasne. The team is approximately 8 people across hardware, mechanical, software, and data science functions, and the company has raised roughly $19.5M across multiple rounds between 2014 and 2024 from investors including SOSV/HAX, Kurma Partners, LBO France, Idinvest, Partech, Seventure Partners, and BPI France.

Short descriptiontext

FeetMe is a Paris-based digital health company that develops CE-marked connected smart insoles with embedded pressure sensors and companion software for clinical gait assessment, diabetic foot monitoring, and athletic performance analysis, sold exclusively to healthcare professionals.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
smart insoles, gait analysis, plantar pressure monitoring, diabetic foot care, medical wearables
Industry4 codes
PRIMARYIMAOAIAI
Specialty & Orthopedic Footwear Manufacturing (Medical/Diabetic/Custom)
SECONDARYHLAHAHAC
Patch Pumps & Wearable Insulin Delivery
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
SECONDARYCRAAACAK
Footwear Components & Materials (Uppers, Soles, Laces, Insoles)
SECONDARYCRAAAEAI
Performance Footwear (Running, Training, Court)
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Footwear Manufacturing3162
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Medical Wearable Devices
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Smart insole hardware sales
TypeHardware Sales
Description

FeetMe sells connected insole hardware products (FeetMe One, FeetMe Diagnosis, FeetMe Sport) directly to healthcare professionals and medical institutions. Products are medical devices marked CE.

feetme.fr
2Software licensing
TypeLicensing Royalties
Description

FeetMe Podiatrist software is part of the solution offering for healthcare professionals to analyze gait and pressure data collected from the smart insoles.

feetme.fr
3Custom orthotics (MySoles)
TypeHardware Sales
Description

FeetMe MySoles system allows podiatrists to design and receive custom orthotic insoles for their patients, creating a product-based revenue stream.

feetme.fr
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
Pricing details1 tier
1Quote-based pricing for healthcare professionals
ModelOtherBilling cadenceMulti-year contract
Notes

No specific pricing tiers publicly available. Direct contact required for quotes and solution customization.

feetme.fr
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1FeetMe One
Description

Medical device connected insole for diabetic patient monitoring, CE marked, designed for daily use with real-time plantar pressure alerts

feetme.fr
+5 more records
Core offering1 text field

FeetMe manufactures and sells connected smart insoles embedded with 80 pressure sensors sampling at 100Hz, designed for healthcare professionals to perform clinical gait analysis and continuous plantar pressure monitoring. The offering combines the hardware insoles with the FeetMe Holter mobile app for data collection and the FeetMe Podiatrist desktop software for computing dynamic and static gait parameters. Product lines include FeetMe One (CE-marked medical device for diabetic foot monitoring), FeetMe Diagnosis (clinical assessment), FeetMe Sport (athletic performance), and FeetMe Mysoles (custom orthotic design and fabrication).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Comprehensive foot-care strategy combining education, prevention, multidisciplinary therapeutic management and close monitoring could reduce amputation rate by up to 85%
+3 more records
Product overview1 text field

FeetMe offers a platform of connected smart insoles for plantar pressure measurement. The core portfolio consists of FeetMe One (CE-marked medical device for diabetic patient monitoring), FeetMe Diagnosis (clinical-grade connected insole), and FeetMe Sport (sports performance variant). Supporting modules include FeetMe Mysoles (custom orthotic design system for podiatrists), FeetMe Holter (mobile data collection app), and FeetMe Podiatrist (analysis software). All products connect via Bluetooth to smartphones for real-time analytics.

Product and service6 records
1FeetMe One
CategoryMedical wearable device
Description

CE-marked connected insole medical device embedded with 80 pressure sensors sampling at 100Hz, designed for diabetic patients to monitor plantar pressure in real time and prevent foot ulcers and amputations. Intended for daily wear in any shoe, with instant alerts when a change in plantar pressure is detected.

2FeetMe Diagnosis
CategoryMedical wearable device
Description

Smart connected insole that measures reliable plantar pressure data and transmits them wirelessly to a device for clinical assessment by health professionals. Used for post-surgery biomechanical assessment, orthotics design, and drop-foot surgery evaluation in podiatry practices.

3FeetMe Sport
CategorySports performance wearable
Description

Technology adapted from the FeetMe platform to analyze sport technique and sport performance, with development of specific metrics to follow and advise athletes in their daily activity.

4FeetMe Mysoles
CategoryCustom orthotic fabrication service
Description

Design and fabrication system of insoles for podiatrists. MySoles offers all tools allowing the podiatrist to design and receive the custom orthotic insoles their patients need.

5FeetMe Holter
CategoryMobile data collection software
Description

Dedicated smartphone application for collecting plantar pressure data anywhere, anytime, with wireless connectivity for data transfer to a computer. Used as part of the FeetMe solution alongside the connected insoles.

6FeetMe Podiatrist
CategoryGait analysis software
Description

Desktop software that computes dynamic parameters including peak pressure maps, pressure-time integral maps, center of pressure movement and variability, the Lateral Medial Force Index, walking symmetry, and temporal gait analysis, plus static analysis metrics such as center of gravity position, velocity and acceleration, confidence ellipse, ANO2X and ANO2Y, Romberg Ratio, and Fourier analysis.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Medical devices and orthotics company. Shown in product imagery alongside FeetMe Diagnosis, suggesting a co-development or distribution partnership for orthotic solutions.

Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Management and technology consulting firm. Listed as a supporter in FeetMe's logo section.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

French association of health technology companies. Listed as a supporter in FeetMe's logo section.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Salfordinsole / Salford Podiatry Lab
TypeDirect peer
Description

Salfordinsole provides podiatry-focused digital insole design and fabrication systems for custom orthotics, including pressure assessment tools. Its offering is highly comparable to FeetMe Mysoles and FeetMe Diagnosis in the podiatry practice workflow for custom orthotic design.

TypeDirect peer
Description

Tekscan manufactures high-resolution pressure mapping systems including in-shoe sensor insoles used in clinical gait analysis, diabetic foot assessment, and sports research. It is the most established direct competitor to FeetMe's pressure-sensor insole platform, with comparable technology positioning and overlapping customer base in podiatry and biomechanics labs.

TypeDirect peer
Description

Digitsole, also a French company, makes connected smart insoles for gait analysis, diabetic foot monitoring, and performance. It is a close direct competitor to FeetMe with overlapping target segments (podiatry, diabetic foot, sports) and similar B2B distribution through healthcare professionals.

TypeEmerging player
Description

Sensoria develops smart insoles and socks with embedded pressure sensors aimed at running, gait, and diabetic foot monitoring. Its consumer and clinical products overlap with both FeetMe Sport and FeetMe One, though Sensoria has historically targeted fitness use cases more than regulated medical indications.

TypeDirect peer
Description

Moticon produces sensor insoles for sports performance and clinical gait monitoring with wireless data capture. It competes directly with FeetMe Sport and FeetMe Diagnosis in the wireless insole category, particularly in running gait analytics and orthopedic rehabilitation use cases.

TypeEmerging player
Description

RunScribe provides wearable gait and running biomechanics analysis tools for athletes and coaches. It overlaps with FeetMe Sport in the athletic-performance segment, though its hardware is attached to shoes rather than embedded in insoles, making it a partial rather than full competitor.

TypeRegional player
Description

Surestep manufactures custom and off-the-shelf medical orthotic insoles primarily for the pediatric and diabetic foot market in North America. It is comparable to FeetMe's Mysoles and FeetMe One product lines in addressing custom orthotic needs for diabetic and at-risk patients, with primary geographic focus in the US rather than Europe.

TypeOthers
Description

Thuasne is a leading European manufacturer of medical devices and orthopedic solutions, including custom orthotics and braces. Although listed as a FeetMe partner, Thuasne is also a potential adjacent competitor/complementor in orthopedic insoles and could choose to develop or distribute competing in-shoe sensor solutions.

TypeDirect peer
Description

Novel (novel.de) produces pedar and emed pressure measurement insoles and platforms widely used in clinical gait analysis, diabetic foot care, and sports biomechanics. Its in-shoe pressure systems directly overlap with FeetMe Diagnosis and FeetMe One in both technology and end-user (podiatrists, orthopedic clinics).

TypeDirect peer
Description

zebris Medical offers instrumented treadmill systems and pressure measurement solutions for gait and posture analysis, serving orthopedic and rehabilitation clinics across Europe. It is a direct competitor in clinical gait analysis workflows that FeetMe Diagnosis targets, with overlapping European clinical customer base.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

FeetMe

Medical Wearable Devicesfeetme.fr

FeetMe is a Paris-based digital health company that develops CE-marked connected smart insoles with embedded pressure sensors and companion software for clinical gait assessment, diabetic foot monitoring, and athletic performance analysis, sold exclusively to healthcare professionals.

What FeetMe does

FeetMe is a Paris-based digital health company founded in 2013 that develops connected smart insoles and companion software for clinical and athletic gait and plantar pressure assessment. Its hardware platform comprises flexible insoles embedded with eighty pressure sensors sampling at 100Hz, communicating via Bluetooth to a smartphone app (FeetMe Holter) and to a clinical desktop application (FeetMe Podiatrist) that computes dynamic and static gait metrics including peak pressure maps, center of pressure movement, walking symmetry, Romberg Ratio, and Fourier analysis. FeetMe One is CE-marked as a medical device and ISO 13485 / ISO 9001 certifications underpin the company's regulatory positioning for diabetic foot monitoring, while FeetMe Diagnosis targets clinical use cases such as post-surgery assessment and orthotic design, and FeetMe Sport and FeetMe Mysoles extend the platform into athletic performance and custom orthotic fabrication respectively.

The company operates a B2B sales-led and enterprise-field-sales go-to-market, selling exclusively to healthcare professionals (podiatrists, sports medicine specialists, hospitals) via direct contact and quote-based pricing with multi-year contracts; it does not sell direct to consumers and instead connects end users to equipped clinicians through a "Find a Specialist" program on its website. Revenue is generated through hardware sales of the smart insole product lines and licensing of the FeetMe Podiatrist analysis software, with FeetMe Mysoles adding an orthotic manufacturing productized workflow supported by a co-development partnership with Thuasne. The team is approximately 8 people across hardware, mechanical, software, and data science functions, and the company has raised roughly $19.5M across multiple rounds between 2014 and 2024 from investors including SOSV/HAX, Kurma Partners, LBO France, Idinvest, Partech, Seventure Partners, and BPI France.

FeetMe firmographics

Firmographics
Name
FeetMe
Legal name
FeetMe
Website
https://feetme.fr
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Short description
FeetMe is a Paris-based digital health company that develops CE-marked connected smart insoles with embedded pressure sensors and companion software for clinical gait assessment, diabetic foot monitoring, and athletic performance analysis, sold exclusively to healthcare professionals.
Ownership category
akta.pro rank

FeetMe industry classification

Industry
Product category
Medical Wearable Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Footwear Manufacturing (3162)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYIMAOAIAI
Specialty & Orthopedic Footwear Manufacturing (Medical/Diabetic/Custom)
SECONDARYHLAHAHAC
Patch Pumps & Wearable Insulin Delivery
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
SECONDARYCRAAACAK
Footwear Components & Materials (Uppers, Soles, Laces, Insoles)
SECONDARYCRAAAEAI
Performance Footwear (Running, Training, Court)

Keywords

  • Smart insoles
  • Gait analysis
  • Plantar pressure monitoring
  • Diabetic foot care
  • Medical wearables

Where FeetMe is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices1 record

Markets served

FeetMe business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

  1. Smart insole hardware sales: FeetMe sells connected insole hardware products (FeetMe One, FeetMe Diagnosis, FeetMe Sport) directly to healthcare professionals and medical institutions. Products are medical devices marked CE.
  2. Software licensing: FeetMe Podiatrist software is part of the solution offering for healthcare professionals to analyze gait and pressure data collected from the smart insoles.
  3. Custom orthotics (MySoles): FeetMe MySoles system allows podiatrists to design and receive custom orthotic insoles for their patients, creating a product-based revenue stream.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractQuote-based pricing for healthcare professionals

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

FeetMe product offering

Product offering

Core offering

FeetMe manufactures and sells connected smart insoles embedded with 80 pressure sensors sampling at 100Hz, designed for healthcare professionals to perform clinical gait analysis and continuous plantar pressure monitoring. The offering combines the hardware insoles with the FeetMe Holter mobile app for data collection and the FeetMe Podiatrist desktop software for computing dynamic and static gait parameters. Product lines include FeetMe One (CE-marked medical device for diabetic foot monitoring), FeetMe Diagnosis (clinical assessment), FeetMe Sport (athletic performance), and FeetMe Mysoles (custom orthotic design and fabrication).

Product overview

FeetMe offers a platform of connected smart insoles for plantar pressure measurement. The core portfolio consists of FeetMe One (CE-marked medical device for diabetic patient monitoring), FeetMe Diagnosis (clinical-grade connected insole), and FeetMe Sport (sports performance variant). Supporting modules include FeetMe Mysoles (custom orthotic design system for podiatrists), FeetMe Holter (mobile data collection app), and FeetMe Podiatrist (analysis software). All products connect via Bluetooth to smartphones for real-time analytics.

Differentiator

Problem solved

Functional benefit

Brands

  • FeetMe One: Medical device connected insole for diabetic patient monitoring, CE marked, designed for daily use with real-time plantar pressure alerts
  • FeetMe Diagnosis
  • FeetMe Sport
  • FeetMe Mysoles
  • FeetMe Podiatrist
  • FeetMe Holter

Products and services

  • FeetMe One CE-marked connected insole medical device embedded with 80 pressure sensors sampling at 100Hz, designed for diabetic patients to monitor plantar pressure in real time and prevent foot ulcers and amputations. Intended for daily wear in any shoe, with instant alerts when a change in plantar pressure is detected.
  • FeetMe Diagnosis Smart connected insole that measures reliable plantar pressure data and transmits them wirelessly to a device for clinical assessment by health professionals. Used for post-surgery biomechanical assessment, orthotics design, and drop-foot surgery evaluation in podiatry practices.
  • FeetMe Sport Technology adapted from the FeetMe platform to analyze sport technique and sport performance, with development of specific metrics to follow and advise athletes in their daily activity.
  • FeetMe Mysoles Design and fabrication system of insoles for podiatrists. MySoles offers all tools allowing the podiatrist to design and receive the custom orthotic insoles their patients need.
  • FeetMe Holter Dedicated smartphone application for collecting plantar pressure data anywhere, anytime, with wireless connectivity for data transfer to a computer. Used as part of the FeetMe solution alongside the connected insoles.
  • FeetMe Podiatrist Desktop software that computes dynamic parameters including peak pressure maps, pressure-time integral maps, center of pressure movement and variability, the Lateral Medial Force Index, walking symmetry, and temporal gait analysis, plus static analysis metrics such as center of gravity position, velocity and acceleration, confidence ellipse, ANO2X and ANO2Y, Romberg Ratio, and Fourier analysis.

Quantifiable outcome

  • Comprehensive foot-care strategy combining education, prevention, multidisciplinary therapeutic management and close monitoring could reduce amputation rate by up to 85%
  • +3 more outcomes

Companies that use FeetMe

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

FeetMe technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

FeetMe partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • ThuasnecoreStrategic or Co-development PartnerMedical devices and orthotics company. Shown in product imagery alongside FeetMe Diagnosis, suggesting a co-development or distribution partnership for orthotic solutions.
  • BearingPointminorImplementation/ SI/ Consulting PartnerManagement and technology consulting firm. Listed as a supporter in FeetMe's logo section.
  • France BiotechminorStrategic or Co-development PartnerFrench association of health technology companies. Listed as a supporter in FeetMe's logo section.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

FeetMe competitors and assessment

Company assessment

Direct peers

  • Salfordinsole / Salford Podiatry Lab: Salfordinsole provides podiatry-focused digital insole design and fabrication systems for custom orthotics, including pressure assessment tools. Its offering is highly comparable to FeetMe Mysoles and FeetMe Diagnosis in the podiatry practice workflow for custom orthotic design.
  • Tekscan: Tekscan manufactures high-resolution pressure mapping systems including in-shoe sensor insoles used in clinical gait analysis, diabetic foot assessment, and sports research. It is the most established direct competitor to FeetMe's pressure-sensor insole platform, with comparable technology positioning and overlapping customer base in podiatry and biomechanics labs.
  • Digitsole: Digitsole, also a French company, makes connected smart insoles for gait analysis, diabetic foot monitoring, and performance. It is a close direct competitor to FeetMe with overlapping target segments (podiatry, diabetic foot, sports) and similar B2B distribution through healthcare professionals.
  • Moticon: Moticon produces sensor insoles for sports performance and clinical gait monitoring with wireless data capture. It competes directly with FeetMe Sport and FeetMe Diagnosis in the wireless insole category, particularly in running gait analytics and orthopedic rehabilitation use cases.
  • Novel GmbH (novel.de): Novel (novel.de) produces pedar and emed pressure measurement insoles and platforms widely used in clinical gait analysis, diabetic foot care, and sports biomechanics. Its in-shoe pressure systems directly overlap with FeetMe Diagnosis and FeetMe One in both technology and end-user (podiatrists, orthopedic clinics).
  • zebris Medical GmbH: zebris Medical offers instrumented treadmill systems and pressure measurement solutions for gait and posture analysis, serving orthopedic and rehabilitation clinics across Europe. It is a direct competitor in clinical gait analysis workflows that FeetMe Diagnosis targets, with overlapping European clinical customer base.

Emerging players

  • Sensoria Fitness: Sensoria develops smart insoles and socks with embedded pressure sensors aimed at running, gait, and diabetic foot monitoring. Its consumer and clinical products overlap with both FeetMe Sport and FeetMe One, though Sensoria has historically targeted fitness use cases more than regulated medical indications.
  • RunScribe: RunScribe provides wearable gait and running biomechanics analysis tools for athletes and coaches. It overlaps with FeetMe Sport in the athletic-performance segment, though its hardware is attached to shoes rather than embedded in insoles, making it a partial rather than full competitor.

Regional players

  • Surestep: Surestep manufactures custom and off-the-shelf medical orthotic insoles primarily for the pediatric and diabetic foot market in North America. It is comparable to FeetMe's Mysoles and FeetMe One product lines in addressing custom orthotic needs for diabetic and at-risk patients, with primary geographic focus in the US rather than Europe.

Others

  • Thuasne: Thuasne is a leading European manufacturer of medical devices and orthopedic solutions, including custom orthotics and braces. Although listed as a FeetMe partner, Thuasne is also a potential adjacent competitor/complementor in orthopedic insoles and could choose to develop or distribute competing in-shoe sensor solutions.

Market position

Strengths5 records

Weaknesses3 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

FeetMe social profiles

Digital presence

FeetMe compliance and trust

Trust signal

Compliance3 records

FeetMe financial estimates

Financial estimate

Revenue estimate

Valuation estimate

FeetMe leadership team

Management profile

Number of profiles

Profiles8 records

FeetMe funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

FeetMe M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FeetMe

What does FeetMe do?

FeetMe manufactures and sells connected smart insoles embedded with 80 pressure sensors sampling at 100Hz, designed for healthcare professionals to perform clinical gait analysis and continuous plantar pressure monitoring. The offering combines the hardware insoles with the FeetMe Holter mobile app for data collection and the FeetMe Podiatrist desktop software for computing dynamic and static gait parameters. Product lines include FeetMe One (CE-marked medical device for diabetic foot monitoring), FeetMe Diagnosis (clinical assessment), FeetMe Sport (athletic performance), and FeetMe Mysoles (custom orthotic design and fabrication).

Is FeetMe a public or private company?

FeetMe is a private company. It is classified as venture growth investor backed and is currently operating.

When was FeetMe founded?

FeetMe was founded in 2013. It employs 11 to 50 people.

Where is FeetMe based?

FeetMe is headquartered in Paris, France, in the Europe region.

How does FeetMe make money?

Three revenue lines are on record. Smart insole hardware sales are the primary driver. The others are software licensing and custom orthotics (MySoles).

Who are FeetMe's main competitors?

Direct peers on record are Salfordinsole / Salford Podiatry Lab, Tekscan, Digitsole, Moticon, Novel GmbH (novel.de) and zebris Medical GmbH. Emerging players are Sensoria Fitness and RunScribe. Surestep is listed as a regional player. Thuasne is listed as an others.

Does FeetMe have an API?

No public API is recorded for FeetMe.

What industry is FeetMe in?

FeetMe's product category is Medical Wearable Devices. Its primary akta.pro industry code is IMAOAIAI, Specialty & Orthopedic Footwear Manufacturing (Medical/Diabetic/Custom), with a secondary code of HLAHAHAC, Patch Pumps & Wearable Insulin Delivery. Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NatureComparison of feetme insoles with a motion capture system coupled to force plates for assessing gait and postureA study compared FeetMe insoles to a motion capture system with force plates in 37 healthy adults, finding equivalence for all gait and posture parameters. Static parameters showed excellent interclass correlation coefficients, and spatiotemporal parameters had excellent accuracy, supporting FeetMe as a valid clinical tool.NatureOverview on wearable sensors for the management of Parkinson’s diseaseA review of wearable sensors for Parkinson's disease management in Europe summarizes devices like PDMonitor, PKG, STAT-ON, and FeetMe, focusing on their role in treatment adjustments. The sensors monitor motor fluctuations, dyskinesia, tremor, and gait, with validation against clinical scales or motion capture. Practical recommendations for daily clinical use remain lacking.FinSMEsFeetMe Raises € 9.4M in Series A FundingFeetMe, a Paris-based gait assessment and rehabilitation company, raised €9.4M in Series A funding led by LBO France. The company will use the funds to accelerate commercial activities. The technology combines pressure and motion sensors to analyze gait and posture in real-world conditions.Business Wire BlogFeetMe, the Leading Provider of Real-World Setting Gait Assessment and Rehabilitation Solutions, Announces the Closing of a Series A Round to Develop New Digital Health Services and Accelerate Its ComFeetMe raised €9.4 million in Series A funding led by LBO France, with participation from existing investors. The funds will accelerate commercial activities, including clinical trials for pharmaceuticals and services for hospitals and rehabilitation facilities. The company's technology analyzes gait and posture in real-world conditions.FinSMEsFeetMe Raises €1.95m in Seed FundingFeetMe, a Paris-based medical device company, raised €1.95m in seed funding led by Kurma Diagnostics, with participation from Idinvest Partners, Seventure, and SOSV. The company produces smart insoles for gait analysis and rehabilitation, and will use the funds to develop its product for therapeutic areas.